The Australian Competition and Consumer Commission has approved an application by plastics manufacturer OxoPak for a certification trade mark for certain biodegradable plastics.
The court has ordered Australia’s biggest internet service providers to block seven websites from “ripping” audio files from music videos on YouTube, in what the judge described as “industrial scale copyright infringement”.
Australian law firm Mills Oakley has established an IP practice in its Melbourne office, snatching a senior lawyer from rival K&L Gates, which is now set to lose five IP specialists in the space of almost two months.
TV giant Foxtel wants another shot at opposing a trade mark by telco China Unicom, after a judge let stand an IP Australia decision refusing to revoke the trade mark when law firm Allens missed a deadline for opposing the mark.
Technology consulting group Infosys must hand over more documents — including source code — to Qudos as the mutual bank considers a possible copyright infringement and breach of contract case in the wake of a soured deal to help overhaul its online banking platform.
A judge has rejected an application by Microsoft to add a claim to its intellectual property dispute with a Melbourne computer retailer after the software giant’s $2.8 million win was overturned as “regrettable” and the case sent back for re-trial.
Chemicals giant BASF has dragged an Australian pest control company to court for allegedly violating its patent for an underground termite control system.
Melbourne-based civic compliance firm SARB Management Group wants to put the brakes on a case brought by tech company Vehicle Monitoring Systems over a patented method for detecting vehicles, in a dispute it says was finalised in a settlement reached almost five years ago.
IP Australia has rejected an application by Huawei Technologies to register the trade mark Nova after a challenge by radio giant Nova Entertainment, with a delegate finding the Chinese telecommunications company had failed to prove its intention to use the mark.
US biotechnology company ICOS has settled a dispute with Australian-based Arrow Pharma over the patents for erectile dysfunction drug Cialis, less than 12 months after a court upheld the validity of the patents in a separate case.